Literature DB >> 1865203

Macrocytosis in multiple sclerosis. A study in 82 de novo Arab patients.

A S Najim al-Din1, M Khojali, H Habbosh, S Farah, A R Idris, F al-Muhtasib.   

Abstract

Macrocytosis, without anaemia, was common in 82 de novo multiple sclerosis patients compared with a similar number of age and sex matched controls. This was an early phenomenon in the course of the disease and was not influenced by the age of the patients nor the duration of the disease. None of the patients proved to have pernicious anaemia, yet the similarity in the geographical and sex distribution as well as the similarity in HLA associations of multiple sclerosis and pernicious anaemia may indicate that both diseases are under similar genetic influence.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1865203      PMCID: PMC488540          DOI: 10.1136/jnnp.54.5.415

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  8 in total

1.  HL-A groups in pernicious anaemia.

Authors:  I Chanarin; S Knight; J O'Brien; D James
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

2.  Multiple sclerosis and macrocytosis.

Authors:  R F Crellin; T Bottiglieri; E H Reynolds
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

3.  Association of pernicious anemia and intrinsic factor antibody with HLA-D.

Authors:  M Thomsen; F Jørgensen; M Brandsborg; P Gimsing; J L Nielsen; L P Ryder; A Svejgaard
Journal:  Tissue Antigens       Date:  1981-01

4.  Vitamin B12 deficiency, demyelination, and multiple sclerosis.

Authors:  E H Reynolds; J C Linnell
Journal:  Lancet       Date:  1987-10-17       Impact factor: 79.321

5.  HLA patterns in pernicious anaemia.

Authors:  B Ungar; J D Mathews; B D Tait; D C Cowling
Journal:  Br Med J       Date:  1977-03-26

6.  HLA antigens in pernicious anaemia.

Authors:  A H Goldstone; D Voak; J C Cawley; W J Irvine
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

7.  Increased incidence of HLA-DR2 in patients with pernicious anemia.

Authors:  E M van den Berg-Loonen; T C Hilterman; M Bins; L E Nijenhuis; C P Engelfriet
Journal:  Tissue Antigens       Date:  1982-02

8.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

  8 in total
  4 in total

1.  Lack of association between macrocytosis and multiple sclerosis.

Authors:  M G Grasso; A Colleluori; E Millefiorini; C Pozzilli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

2.  The Effect of Vitamin B12 and Folic Acid Supplementation on Serum Homocysteine, Anemia Status and Quality of Life of Patients with Multiple Sclerosis.

Authors:  Ehsan Nozari; Saied Ghavamzadeh; Nazanin Razazian
Journal:  Clin Nutr Res       Date:  2019-01-25

Review 3.  The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders.

Authors:  T Bottiglieri; K Hyland; E H Reynolds
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

4.  Effect of Whole-Body Cryotherapy on Morphological, Rheological and Biochemical Indices of Blood in People with Multiple Sclerosis.

Authors:  Bartłomiej Ptaszek; Aneta Teległów; Justyna Adamiak; Jacek Głodzik; Szymon Podsiadło; Dawid Mucha; Jakub Marchewka; Tomasz Halski; Dariusz Mucha
Journal:  J Clin Med       Date:  2021-06-27       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.